Breakpoints cover image

#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials

Breakpoints

00:00

Hiv Aids

The first one is looking at single dose liposomal amphitheresin B in the treatment of disseminated histoplasmosis. The phase two trial that's based on this is enrolling right now. All patients got itra conazole capsules 400 milligrams a day. And I see I know we all have feelings about itra Conazole capsule. So we'll hold our peanut gallery comments, but everybody got itraconazole capsules for I can't I can't hold my peanut gallery. Go for it! You're okay. But if you only have capsules, then of course, treat your patient. If they had TB and Rifampa was going to

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app